Skip to main content
SpringerLink
Log in
Book cover

Therapy of Renal Diseases and Related Disorders pp 581–591Cite as

Inherited Renal Tubular Disorders

  • Chapter

  • 173 Accesses

Abstract

A number of clinical syndromes have been described that have as their basic foundation a defect in some transport function of the renal tubule (Table 1). Using this paradigm, one can define conditions in which single or multiple substances are lost, in which ions or organic solutes are lost, and in which the whole body pools of these substances are altered because of excessive urinary excretion. The basic pathophysiologic mechanisms underlying these transport disorders are described elsewhere (1–4). The purpose of this chapter is to describe the current form of therapy in these conditions.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Scriver CR, Chesney RW, Mclnnes RR: Genetic aspects of renal tubular transport. Diversity and topology of carriers. Kidney Int 9:149–171, 1976.

    Article  PubMed  CAS  Google Scholar 

  2. Schneider JA: Hereditary disorders of tubular function. In: BM Tune, SA Mendoza, eds, Pediatric Nephrology. Contemporary Issues in Nephrology, 12th issue, Churchill-Livingston, New York, pp 85–109, 1984.

    Google Scholar 

  3. Chesney RW: Defects of renal tubular transport. In: SG Massry, R Glassock, eds, Textbook of Nephrology. Elsevier, North Holland, pp 3.178–3.190, 1983.

    Google Scholar 

  4. Chesney RW, Friedman AL: Isolated renal tubular disorders. In: RW Schrier, CW Gottschalk, eds, Diseases of the Kidney, 4th ed., pp 663–688, 1988.

    Google Scholar 

  5. Scriver CR: Familial iminoglycinuria. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 1792–1803, 1983.

    Google Scholar 

  6. Melanan SB, Dallaire L, Lemieux B, Robitaille P, Portier M: Dicarboxylic aminoaciduria: An inborn error of amino acid conservation. J Pediatr 94:422–427, 1977.

    Google Scholar 

  7. Foreman JW, Segal S: Aminoacidurias. In: HC Gorick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 131–157, 1985.

    Google Scholar 

  8. Segal S, Thier SO: Cystinuria. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 1174–1791, 1983.

    Google Scholar 

  9. Pak CYC, Fuller CJ: Assessment of cystine solubility in urine and of heterogeneous nucleation. J Urol 129:1066–1074, 1983.

    PubMed  CAS  Google Scholar 

  10. Pak CYC, Fuller C, Sakhaee K, Zerwekh JE, Adams BV: Management of cystine nephrolithiasis with alphamercaptopropinyl-glycine. J Urol 136:1003–1008, 1986.

    PubMed  CAS  Google Scholar 

  11. Harbar JA, Cusworth DC, Lawes LC, Wrong OM: Comparison of 2-mercaptopropronyl-glycine and D-penicillamine in the treatment of cystinuria. J Urol 136: 146–149, 1986.

    PubMed  CAS  Google Scholar 

  12. Rodman JS, Blackburn P, Williams JJ, Brown A, Poapiaxhil MA, Peterson CM: The effect of dietary protein on cystine excretion in patients with cystinuria. Clin Nephrol 22:273–278, 1984.

    PubMed  CAS  Google Scholar 

  13. Skovby F, Rosenberg LE, Thiers SO: No effect of L-glutamine on cystinuria. N Engl J Med 302:236–237, 1980.

    Article  PubMed  CAS  Google Scholar 

  14. Jaeger P, Portmann L, Saunders A, Rosenberg LE, Thier SO: Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315:1120–1123, 1986.

    Article  PubMed  CAS  Google Scholar 

  15. Bass RB, Beard JH, Cooner WH, Mosley BR, Pond HS, Rutherford CL, Jr: Percutaneous ultrasonic lithotrypsy in the community hospital. J Urol 133:1586–1587, 1985.

    Google Scholar 

  16. Brannen GE, Bush WH: Percutaneous ultrasonic versus surgical removal of kidney stones. Surg Gynecol Obstet 161:473–478, 1985.

    PubMed  CAS  Google Scholar 

  17. Grantham JR, Millner MR, Kande JV, Findlayson B, Hunter PT, Newman RC: Renal stone disease treated with extracorporeal shock wave lithotrypsy: Short term observations in 100 patients. Radiology 158:203–206, 1986.

    PubMed  CAS  Google Scholar 

  18. Wen SF: Glycosurias In:HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders, Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 131–157, 1985.

    Google Scholar 

  19. McSherry E: Renal tubular acidosis in childhood. Kidney Int 20:799–809, 1981.

    Article  PubMed  CAS  Google Scholar 

  20. Batlle DC, Kurtzman NA: The defect in distal (Type I) renal tubular acidosis. In: HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders, Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 281–305, 1985.

    Google Scholar 

  21. Buckalew VM Jr, Carvana RJ: The pathophysiology of distal (Type I) renal tubular acidosis. In: HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders, Pathology Diagnosis and Management. Marcel Dekker, New York, pp 357–386, 1985.

    Google Scholar 

  22. McSherry E: Acidosis and growth in nonuremic renal disease. Kidney Int 14:349–354, 1978.

    Article  PubMed  CAS  Google Scholar 

  23. Brenner RJ, Spring DB, Sebastian A, McSherry EM, Genant HK, Palubinskas AJ, Morris RC Jr: Incidence of radiographically evident bone disease, nephrocalcinosis and nephrolithiasis in various types of renal tubular acidosis. N Engl J Med 307:217–222, 1982.

    Article  PubMed  CAS  Google Scholar 

  24. Buckalew VM Jr, Purvis ML, Shulman MG, Herndon CN, Rudman D: Hereditary renal tubular acidosis. Report of 64 member kindred with variable clinical expression including idiopathic hypercalciuria. Medicine 53:229–254, 1954.

    Google Scholar 

  25. Edelmann CM Jr: Isolated proximal (Type II) renal tubular acidosis. In: HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders. Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 261–280, 1985.

    Google Scholar 

  26. Donckerwolcke RA, Van Stekelenburg GJ, Tiddens HA: Therapy of bicarbonate-losing renal tubular acidosis. Arch Dis Child 45:774–779, 1970.

    Article  PubMed  CAS  Google Scholar 

  27. Boyer M, Proesmans W, Royer P: La titration des bicarbonates chez l’enfant normal et au cours de diverses nephropathies. Rev Ethudes Clin Biol 14:556–568, 1969.

    Google Scholar 

  28. Sebastian A, Schambelan M, Hulter HN, Maher T, Kurtz I, Biglieri EG, Rector FC Jr, Morris RC Jr: Hyperkalemic renal tubular acidosis. In: HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders, Pathophysiology, Diagnosis and Management. Marcel Dekker, New York, pp 307–356, 1985.

    Google Scholar 

  29. Batlle DC, Arruda JAL, Kurtzman NA: Hyperkalemic distal renal tubular acidosis associated with obstructive uropathy. N Engl J Med 304:373–380, 1981.

    Article  PubMed  CAS  Google Scholar 

  30. Cheek DB, Perry JW: A salt wasting syndrome in infancy. Arch Dis Child 33:252–256, 1958.

    Article  PubMed  CAS  Google Scholar 

  31. Chesney RW: Renal tubular disorders. In: HC Gonick, ed, Contemporary Nephrology. Yearbook Medical Publishers, Chicago, 11:107–138, 1988.

    Google Scholar 

  32. Armanini D, Kuhnle U, Strasser T, Dorr H, Butenandt T, Weber PC, Stockigt JR, Pearce P, Funder JW: Aldosterone-receptor deficiency in pseudohypoaldosteronison. TV Engl J Med 313:1178–1181, 1985.

    Article  CAS  Google Scholar 

  33. Oberfield SE, Levine LS, Carey RM, Bejark B, New MI: Pseudohypoaldosteronism: Multiple target organ unresponsiveness to mineralocorticoid hormones. J Clin Endocrinol Metab 48:228–234, 1979.

    Article  PubMed  CAS  Google Scholar 

  34. De Fronzo RA: Hyperkalemia and hyporenienemic hypoal-dosteronism. Kidney Int 29:186–202, 1980.

    Google Scholar 

  35. Schambelain M, Sebastian A, Biglieri EG: Prevalence, pathogenesis and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int 17:89–94, 1980.

    Article  Google Scholar 

  36. Massry SG, Fredley RM, Coburn JW: Excretion of phosphate and calcium: Physiology of their renal handling and relation to clinical medicine. Arch Intern Med 131:828–859, 1973.

    Article  PubMed  CAS  Google Scholar 

  37. Chesney RW: Phosphaturic syndromes. In: H Gonick, VM Buckalow Jr, eds, Renal Tubular Disorders. Marcel Dekker, New York, pp 201–238, 1985.

    Google Scholar 

  38. Tenenhouse HS: Effect of age and the X-linked hyp/y mutation on renal adaptation to vitamin D and calcium deficiency. Can Biochem Physiol 81A:367–371, 1985.

    Article  CAS  Google Scholar 

  39. Tenenhouse HS: Abnormal renal mitrochondrial 25-hydroxyvitamin D-1α-hydroxylase activity in the vitamin D and calcium deficient X-linked hyp/y mouse. Endocrinology 113:816–818, 1983.

    Article  PubMed  CAS  Google Scholar 

  40. Drezner MK, Lyles KW, Haussler MR, Harrelson JM: Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest 66:1020–1032, 1980.

    Article  PubMed  CAS  Google Scholar 

  41. Chesney RW, Mazess RB, Rose P, Hamstra AJ, DeLuca HF, Breed AL: Long-term influence of calcitrol (1,25 dihyd-roxvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Pediatrics 71:559–567, 1983.

    PubMed  CAS  Google Scholar 

  42. Marie PJ, Glorieux FM: Histromorphometric study of bone remodeling in hypophosphatemic vitamin D-resistant rickets. Metab Bone Dis Rel Res 3:31–39, 1981.

    Article  CAS  Google Scholar 

  43. Glorieux FH, Scriver CR, Reade TM, Goldman H, Roseborough A: Use of phosphate and vitamin D to prevent dwarfism and rickets in X-linked hypophosphatemic rickets. N Engl J Med 287:481–485, 1972.

    Article  PubMed  CAS  Google Scholar 

  44. Polisson RB, Martinez SJ, Khoury M, Harrell RM, Lyles KW, Friedman N, Harrelson JM, Reisner E, Drezner MK: Calcification of enthesis associated with X-linked hypophosphatemic osteomalacia. N Engl J Med 313:1–6, 1985.

    Article  PubMed  CAS  Google Scholar 

  45. Scriver CR: On phosphate transport and genetic screening, “understanding backward-living forward” in human genetics: William Allen Memorial Award Address. Am J Hum Genet 31:243–248, 1979.

    PubMed  CAS  Google Scholar 

  46. Terder M, Modai D, Samuel R, Arie R, Malabe A, Bab I, Gabizon D, Lieberman VA: Hereditary hypophosphatemic rickets with hypercalciuria. N Engl J Med 312:611–616, 1985.

    Article  Google Scholar 

  47. Harrison HE, Harrison HC: Rickets and osteomalacia. In: Major Problems in Clinical Pediatrics: Disorders of Calcium and Phosphate Metabolism in Childhood and Adolescence. WB Saunders, Philadelphia, vol. xx, pp 141–256, 1979.

    Google Scholar 

  48. Drezner MK, Feinglos MN: Ostemalacia due to 1,25-dihydroxycholecalciferol deficiency. J Clin Invest 60:1046–1053, 1977.

    Article  PubMed  CAS  Google Scholar 

  49. Dent CE, Stamp TCB: Hypophosphatemic osteomalcia presenting in adults. Q J Med 40:303–329, 1971.

    PubMed  CAS  Google Scholar 

  50. Lundberg E, Bergengren H, Lundquist B: Mild phosphate diabetes in adults. Acta Med Scand 204:93–96, 1978.

    Article  PubMed  CAS  Google Scholar 

  51. Dent CE, Friedman M: Hypophosphatemic osteomalacia with complete recovery. Br Med J 1:1676–1679, 1964.

    PubMed  CAS  Google Scholar 

  52. Booth BE, Johanson A: Hypomagnesiemia due to renal tubular defect in reabsorption of magnesium. J Pediatr 84:350–354, 1974.

    Article  Google Scholar 

  53. Evans RA, Carter JN, George CRP, et al.: The congenital magnesium losing kidney. Q J Med 197:39–52, 1981.

    Google Scholar 

  54. Agus ZS, Wasserstein A, Goldfarb S: Disorders of calcium and magnesium homeostasis. Am J Med 72:473–488, 1982.

    Article  PubMed  CAS  Google Scholar 

  55. Rude RK, Oldham SB, Singer FR: Functional hypopoar-thyroidism and parathyroid hormone end-organ resistance in human magnesium deficiency. Clin Endocrinol 5:209–214, 1976.

    Article  CAS  Google Scholar 

  56. Duran MJ Borst GC, Osburne RC, Eil C: Concurrent renal hypomagnesemia and hypoparathyroidism with normal parathormone responsiveness. Am J Med 76:151–154, 1984.

    Article  PubMed  Google Scholar 

  57. Ralston S, Boyle IT, Cowan RA, Creau GP, Jenkins A, Thomson WS: PTH and vitamin D responses during treatment of hypomagnesiemia hypoparathyroidism. Acta Endocrinol 103:535–538, 1983.

    PubMed  CAS  Google Scholar 

  58. Rude RK, Adams JS, Ryzen E, Endres DB, Niimi H, Horst RL, Haddad JG, Singer FR: Low serum concentrations of 1,25 dehydroxyvitamin D in human magnesium deficiency. J Clin Endocrinol Metab 61:933–940, 1985.

    Article  PubMed  CAS  Google Scholar 

  59. Zelikovic I, Dabbagh S, Friedman AL, Goelzer ML, Chesney RW: Severe renal osteodystrophy without elevated serum immunorective parathyroid hormone concentrations in hypomagnesemia due to renal magnesium wasting. Pediatrics 79:403–409, 1987.

    PubMed  CAS  Google Scholar 

  60. Allen DB, Friedman AL, Greer FR, Chesney RW: Hypomagnesemia masking the appearance of elevated parathyroid hormone concentrations in familial pseudohypoparathyroidism. Am J Med Genet 31:153–158, 1988.

    Article  PubMed  CAS  Google Scholar 

  61. Brewer ED: The Fanconi syndrome: Clinical disorders. In: HC Gonick, VM Buckalew Jr, eds, Renal Tubular Disorders. Marcel Dekker, New York, pp 475–544, 1985.

    Google Scholar 

  62. Chesney RW: Etiology and pathogenesis of the Fanconi syndrome. Miner Electrolyte Metab 4:303–316, 1980.

    Google Scholar 

  63. Wallis LA, Engle RL: The adult Fanconi syndrome II: Review of eighteen cases. Ann J Med 22:13–23, 1957.

    Article  Google Scholar 

  64. Gahl WA: Cystinosis coming of age. Adv Pediatr 33:95–126, 1986.

    PubMed  CAS  Google Scholar 

  65. Schneider JA: Therapy of cystinosis. N Engl J Med 313:1473–1474, 1985.

    Article  PubMed  CAS  Google Scholar 

  66. Gahl WA, Thoene JG, Schneider JA, Mendoza SA, Schulman JG: Results of the national collaborative cystamine study: Improvement in linear growth and slowed progression of renal failure. N Engl J Med 366:971–977, 1987.

    Article  Google Scholar 

  67. Gahl WA, Schneider JA, Thoene JG, Chesney RW: Course of nephropathy cystinosis after 10 years of age. J Pediatr 109:605–608, 1986.

    Article  PubMed  CAS  Google Scholar 

  68. Bennardini I, Rizzo WB, Dalakas M, Berner J, Gahl WA: Plasma and muscle free carnitine deficiency due to renal Fanconi syndrome. J Clin Invest 75:1124–1130, 1985.

    Article  Google Scholar 

  69. Abassi V, Lowe CU, Calcagno PL: Oculo-cerebro-renal syndrome. A review. Am J Dis Child 115:145–168, 1968.

    Google Scholar 

  70. Segal S: Disorders of galactose metabolism. In: JB Stanbury, JB Wyngaarden, DS Frederickson, JL Goldstein, MS Brown, eds, The Metabolic Basis of Inherited Disease, 5th ed. McGraw-Hill, New York, pp 166–191, 1983.

    Google Scholar 

  71. Lindblad B, Lindstedt S, Steen G: On the enzymic defects in hereditary tyrosinemua. Proc Natl Acad Sci USA 74:4641–4645, 1977.

    Article  PubMed  CAS  Google Scholar 

  72. Scriver CR, Silverberg M, Clow CL: Hereditary tyrosinemia and tyrosyluria: Clinical report of four patients. Can Med Assoc J 97:1047–1050, 1967.

    PubMed  CAS  Google Scholar 

  73. Steinmann B, Gitzelmann R: The dignosis of hereditary fructose intolerance. Helv Pediatr Acta 36:297–316, 1981.

    CAS  Google Scholar 

  74. Chesney RW, Kaplan BS, Teitel D, Colle E, McInnes RR, Goldman M, Scriver CR: Metabolic abnormalities in the idiopathic Fanconi syndrome: Studies of carbohydrate metabolism in two patients. Pediatrics 67:113–118, 1981.

    PubMed  CAS  Google Scholar 

  75. Brodehl J, Gelessen K, Hagge W: The Fanconi syndrome in hepatorenal glycogen storage disease in progress. In: G Peiters, Roch-Rainel F, eds, Nephrology. Springer-Verlag, New York, pp 241–243, 1969.

    Google Scholar 

  76. Strickland GT, Lew ML: Wilson’s disease, clinical and laboratory manifestations in 40 patients. Medicine 54:113–137, 1975.

    PubMed  CAS  Google Scholar 

  77. Beam AG, Yu TF, Gutman AB: Renal function in Wilson’s disease. J Clin Invest 36:1107–1114, 1957.

    Article  Google Scholar 

  78. Walshe JM: Effect of penicillamine on failure of renal acidification in Wilson’s disease. Lancet 1:775–779, 1985.

    Google Scholar 

  79. Walshe JM: Treatment of Wilson’s disease with trientine (trithlene tetramine) dihydrochloride. Lancet 1:643–647, 1982.

    Article  PubMed  CAS  Google Scholar 

  80. Maldonado JE, Velosa JA, Kyle RA, Wagoner RD, Molley KE, Salassa RM: Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med 58:354–364, 1975.

    Article  PubMed  CAS  Google Scholar 

  81. Burke EC, Holley KE, Stickler GB: Familial nephrotic syndrome with nephrocalcinosis and tubular dysfunction. J Pediatr 82:202–206, 1973.

    Article  PubMed  CAS  Google Scholar 

  82. Bergstein JM, Litman N: Interstitial nephritis with antitubular-basement-membrane antibody. N Engl J Med 292:875–878, 1975.

    Article  PubMed  CAS  Google Scholar 

  83. Friedman AL, Chesney RW: Fanconi’s syndrome in renal transplantation. Am J Nephrol 1:45–47, 1981.

    Article  PubMed  CAS  Google Scholar 

  84. Mavromatis F: Tetracyline nephropathy. JAMA 193:10: 191–194, 1965.

    Google Scholar 

  85. Otter J, Vis HL: Acute reversible renal tubular dysfunction following intoxication with methyl-3-chromone. J Pediatr 73:422–425, 1968.

    Article  Google Scholar 

  86. Chrisolm JJ: Increased lead absorption and lead poisoning. In: RE Behrman, Vaughn VC, eds, Nelson Textbook of Pediatrics, 11th ed. WB Saunders, Philadelphia, pp 1801–1804, 1983.

    Google Scholar 

  87. Hoakawa Y, Abe J, Tamaka S: Bone changes in experimental chronic cadmium poisoning. Arch Environ Health 26:241–244, 1973.

    Google Scholar 

  88. Chesney RW, Harrison HE: Fanconi syndrome following bowel surgery and hepatitis reversed by 25-hydroxy-cholecalciferol. J Pediatr 86:857–861, 1975.

    Article  PubMed  CAS  Google Scholar 

  89. Gill JR Jr: Bartter’s syndrome. In: HC Gonick, Buckalew VM Jr, eds, Renal Tubular Disorders. Marcel Dekker, New York, pp 457–473, 1985.

    Google Scholar 

  90. Tomko DJ, Yeh BPY, Falls WF Jr: Bartter’s syndrome. Study of a 52 year old man with evidence for a defect in proximal tubular sodium reabsorption and comments on therapy. Am J Med 61:111–117, 1976.

    Article  PubMed  CAS  Google Scholar 

  91. Pererra RR, Von Wersch J: Inheritance of Bartter syndrome. Am J Med Genet 15:79–84, 1983.

    Article  Google Scholar 

  92. White MG: Bartter’s syndrome. A manifestation of renal tubular defects. Arch Intern Med 129:41–47, 1972.

    Article  PubMed  CAS  Google Scholar 

  93. Gill JR, Frohlich JC, Bowden RE, Taylor AA, Keiser HR, Seyberth HV, Oates JA, Bartter FC: Bartter’s syndrome: A disorder characterized by high urinary prostaglandins and dependence of hypereninemia on prostaglandin synthesis. Am J Med 61:43–51, 1976.

    Article  PubMed  Google Scholar 

  94. Halushka PV, Wohltmann H, Privitera PJ, Hurwitz G, Margolius HS: Bartter’s syndrome: Urinary prostaglandin E-like material and kallikrein; indomethacin effects. Ann Intern Med 87:281–286, 1977.

    PubMed  CAS  Google Scholar 

  95. Veldhius JD, Bardin CW, Demers LM: Metabolic mimcry of Bartter’s syndrome to covert vomiting. Am J Med 66:361–363, 1979.

    Article  Google Scholar 

  96. Stein JH: The pathogenic spectrum of Bartter’s syndrome. Kidney Int 28:85–93, 1985.

    Article  PubMed  CAS  Google Scholar 

  97. Seyberth HW, Rascher W, Schweer H, Kuhl PG, Mehls O, Scharer K: Congenital hypokalemia with hypercalcemia in preterm infants. A hyperprostaglandinuric tubular syndrome different from Bartter syndrome. J Pediatr 107:694–698, 1985.

    Article  PubMed  CAS  Google Scholar 

  98. Hornuch I, Huet de Barochez Y, Bariety J, Branca GF, Vigeral P, Girard JF, Kazatchkine M, DeGennes JL, Truffert J, Bocquet L, Paris M: Bartter’s syndrome with normal sodium chloride reabsorption during indomethacin treatment. Nephron 46:137–143, 1987.

    Article  Google Scholar 

  99. Gullner HC, Bartter FC, Gill JR Jr, Bickman PS, Wilson CB, Tiwari JL: A subship with hypokalemic alkalosis and renal proximal tubulopathy. Arch Intern Med 143:1534–1537, 1983.

    Article  PubMed  CAS  Google Scholar 

  100. Fishman MP, Telfer N, Zia P, Speckart P, Golub M, Rude R: Role of prostaglandins in the pathogenesis of Bartter’s syndrome. Am J Med 60:785–797, 1976.

    Article  Google Scholar 

  101. Griffing GT, Melby JC: The therapeutic use of a new potassium-sparing diuretic, amiloride and converting enzyme inhibitor, MK421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism. Clin Exper Hypertens A5:779–801, 1983.

    Article  Google Scholar 

Download references

Authors
  1. Russell W. Chesney
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Baylor College of Medicine, The Methodist Hospital, Houston, Texas, USA

    Wadi N. Suki

  2. Division of Nephrology, University of Southern California, Los Angeles, California, USA

    Shaul G. Massry

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Kluwer Academic Publishers

About this chapter

Cite this chapter

Chesney, R.W. (1991). Inherited Renal Tubular Disorders. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_37

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-0689-4_37

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8027-9

  • Online ISBN: 978-1-4613-0689-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation